Chadwick Jeremy G sold KYMR
April 22, 2026 · Form 4 insider transaction
Chadwick Jeremy G sold 300 shares of Kymera Therapeutics, Inc. at $90.00 per share, a transaction worth $27.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$90.00
Total value
$27.0K
InsiderChadwick Jeremy G
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 22, 2026
Filing dateApril 24, 2026
Shares owned after61,202
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.